she s like confetti after people say, what a mess. fox news contributor, cath. and finally, he s got a gold chain and a silver tongue, my massive side kick in the nwa s world heavyweight champion. judge. what? welcome to the show. always a pleasure. you re like an ex-wife i never had. yeah, yeah, never wanted. yeah, i feel like oscar from the odd couple. an meira. you re older than i am. why would i remember? ann mirra. wasn t it two guys. felix unger. he had an ex-wife. he gets kicked out at the start of the odd cup. never saw that. two guys. you never saw oscar s wife, she called and asked for money. really? this is a recovered memory, a
we re delivering into the body. in addition, at meira, we ve actually developed, over the last seven years, a totally new technology which allows us to, in the future, control how those genes delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells and green are the cone cells, so they exist in this kind of mosaic. early results of using gene therapy to treat retinitis pigmentosa has shown that it could potentially not only slow the progression of the disease, but in some cases reverse some of its effects.
started, one of the big issues was how do you get those genes into people? so we, and others, over the last five to ten years, have developed a new viral vector, and we re manufacturing that here to deliver the genes we re delivering into the body. in addition, at meira, we ve actually developed, over the last seven years, a totally new technology which allows us to, in the future, control how those genes delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells and green are the cone cells, so they exist in this kind of mosaic. early results of using gene
here to deliver the genes we re delivering into the body. in addition, at meira, we ve actually developed, over the last seven years, a totally new technology which allows us to, in the future, control how those genes delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmentosa. it causes light detecting cells in the retina to break down over time, causing a person to eventually lose vision. red are the rod cells and green are the cone cells, so they exist in this kind of mosaic. early results of using gene therapy to treat retinitis pigmentosa has shown that it could potentially not only slow the progression